Info
AE_TAS102
**Administration: 35mg/m2 BID (5/2) for 2 weeks, and 2 weeks off **AEs such as n/v, anorexia, fatigue, diarrhea, pancytopenia, abnormal LFTs, and FN but only 4%. .AETAXOL explain the AEs of taxol, such as myelosuppression, hand-foot-syndrome, mainly sensory neuropathy, alopexia, mucositis and/or diarrhea, and hypersensitivity reaction. **Emphasize the importance of nutrional support (high protein diet) during C/T period.
Siblings
- AE_ABVD
- AE_ACT
- AE_ALECTINIB
- AE_ALIMTA
- AE_ALPELISIB
- AE_BENDAMUSTINE
- AE_CCRT
- AE_CDK46
- AE_CRIZOINIB
- AE_DABRAFENIB
- AE_ENHERTU
- AE_ERIBULIN
- AE_FOLFOX
- AE_GLIVEC
- AE_HERCEPTIN
- AE_LANREOTIDE
- AE_LAPATINIB
- AE_LAR
- AE_LETROZOLE
- AE_OLAPARIB
- AE_OSIMERTINIB
- AE_PAZOPANIB
- AE_PEMIGATINIB
- AE_PERTUZUMAB
- AE_RAMUCIRUMAB
- AE_RECTAL
- AE_REGORAFENIB
- AE_SORAFENIB
- AE_SUNITINIB
- AE_TAS102
- AE_TAXOTERECDDP
- AE_TOPOTECAN
- AE_UFT
- AE_VEMURAFENIB
- AE_VINORELBINE
- AE_XELOX